NEWS

LINNC Americas postponed!

First US treatment of 3 patients with the FRED device

Cerus Endovascular Successfully Completes Series B Financing and Receive...

FREMONT, Calif. and OXFORD, England, Feb. 21, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has now successfully completed its Series B financing having raised a total of $19.0 million from current and new institutional investors since commencement of the round in July 2018. The company also reported that it has received approval from the U.S. Food and Drug Administration (FDA) for its first microcatheter. Commercial sales are expected to begin during the second quarter of 2020.

Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascul...

FREMONT, Calif. and OXFORD, England - Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of intracranial aneurysms.

Thrombectomy - ADAPT with Snake bite technique

Cascade Net – an innovative non-occlusive remodeling device for temporar...

Multi-center clinical experience in 15 cases with the innovative CE-marked Cascade Net device was highlighted in the January 2020 Journal of Neurosurgery article, “Early experience with a novel net temporary bridging device (Cascade) to assist endovascular coil embolization of intracranial aneurysms” by Dr Alejandro Tomasello et al*.

Cascade Net – a non-occlusive remodeling device

Ascending pharyngeal with its “dangerous” anastomoses

YouTube Contest - Win your ticket to the LINNC!